Global burden of cardiovascular diseases and risk factors, 19902019: update from the GBD 2019 study
In this study, we developed an innovative dry powder inhaler (DPI) formulation co-loading ciprofloxacin-encapsulated liposomes (CIP-Lips) and S-nitrosoglutathione (GSNO) using an ultrasonic spray-freeze-drying (USFD) technique
Poole LP, Macleod KF
These treatments primarily aim to manage symptoms, encourage hair regrowth, and prevent further progression of the disease, though their efficacy can vary based on disease severity and individual response
10 Ongoing trials are currently studying semaglutide and tirzepatide for alcohol use disorder, semaglutide for opioid use and cannabis use disorder, liraglutide for opioid use disorder, and semaglutide and exenatide to achieve smoking cessation
S., Lightowler, H., Ahlstrom, L., & Gallagher, A